- Home
- AQN vs MRUS Comparison
AQN vs MRUS Comparison
Compare AQN & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQN
- MRUS
- Stock Information
- Founded
- AQN 1988
- MRUS 2003
- Country
- AQN Canada
- MRUS Netherlands
- Employees
- AQN N/A
- MRUS N/A
- Industry
- AQN Electric Utilities: Central
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- AQN Utilities
- MRUS Health Care
- Exchange
- AQN Nasdaq
- MRUS Nasdaq
- Market Cap
- AQN 4.4B
- MRUS 4.1B
- IPO Year
- AQN 1998
- MRUS 2016
- Fundamental
- Price
- AQN $5.92
- MRUS $63.26
- Analyst Decision
- AQN Hold
- MRUS Strong Buy
- Analyst Count
- AQN 8
- MRUS 13
- Target Price
- AQN $6.28
- MRUS $88.54
- AVG Volume (30 Days)
- AQN 7.7M
- MRUS 603.8K
- Earning Date
- AQN 08-08-2025
- MRUS 07-31-2025
- Dividend Yield
- AQN 4.39%
- MRUS N/A
- EPS Growth
- AQN N/A
- MRUS N/A
- EPS
- AQN N/A
- MRUS N/A
- Revenue
- AQN $2,365,738,000.00
- MRUS $54,732,000.00
- Revenue This Year
- AQN $4.42
- MRUS $68.08
- Revenue Next Year
- AQN $3.80
- MRUS $0.09
- P/E Ratio
- AQN N/A
- MRUS N/A
- Revenue Growth
- AQN 4.15
- MRUS 42.77
- 52 Week Low
- AQN $4.19
- MRUS $33.19
- 52 Week High
- AQN $6.36
- MRUS $63.43
- Technical
- Relative Strength Index (RSI)
- AQN 60.25
- MRUS 74.17
- Support Level
- AQN $5.81
- MRUS $54.09
- Resistance Level
- AQN $5.92
- MRUS $56.60
- Average True Range (ATR)
- AQN 0.10
- MRUS 1.97
- MACD
- AQN 0.01
- MRUS 0.77
- Stochastic Oscillator
- AQN 80.56
- MRUS 98.54
About AQN Algonquin Power & Utilities Corp.
Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units consisting of the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.